ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,066.00
      -0.07%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.67%
      Bitcoin
      66,873.04
      2.50%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. NFL Biosciences SA (ALNFL)

      7. NFL Biosciences SA (ALNFL) News

      ALNFL

      NFL Biosciences (ALNFL)

      NFL Biosciences SA
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:ALNFL
      DateTimeSourceHeadlineSymbolCompany
      3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
      07/18/20232:00AMGlobeNewswire Inc.NFL BIOSCIENCES : DÉPÔT D’UNE DEMANDE DE BREVET AUX ÉTATS-UNIS DÉDIÉE À LA RÉDUCTION DE LA CONSOMMATION D’ALCOOL AVEC NFL-301 & PRÉPARATION D’UNE DEMANDE DE PRE-IND AUPRÈS DE LA FDAEU:ALNFLNFL Biosciences SA
      07/18/20232:00AMGlobeNewswire Inc.Nfl Biosciences: Patent Application Filed in the United States for Reducing Alcohol Consumption With Nfl-301 & Preparation of a Pre-Ind Application Submission With the FdaEU:ALNFLNFL Biosciences SA
      07/11/202311:45AMGlobeNewswire Inc.BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ : 1er SEMESTRE 2023EU:ALNFLNFL Biosciences SA
      07/11/202311:45AMGlobeNewswire Inc.NFL BIOSCIENCES CONFIRME LE RENOUVELLEMENT DE SON ELIGIBILITE AU PEA-PMEEU:ALNFLNFL Biosciences SA
      07/05/20231:00PMGlobeNewswire Inc.NFL BIOSCIENCES : RENFORCEMENT D’UN ACTIONNAIRE FONDATEUR PAR EXERCICE DE BSPCEEU:ALNFLNFL Biosciences SA
      07/05/20231:00PMGlobeNewswire Inc.NFL BIOSCIENCES: CO-FOUNDER SHAREHOLDER FURTHER STRENGTHENS HIS POSITION BY EXERCISING “BSPCE” WARRANTSEU:ALNFLNFL Biosciences SA
      06/29/202311:45AMGlobeNewswire Inc.NFL BIOSCIENCES: GB HOLDING TAKES A STAKE IN THE COMPANY’S CAPITAL UPON THE EXERCISE OF SHARE SUBSCRIPTION WARRANTS AND PAYMENT OF 0.5M€, AND ALSO COMMITS TO A LOCK-UPEU:ALNFLNFL Biosciences SA
      06/29/202311:45AMGlobeNewswire Inc.NFL BIOSCIENCES : MONTÉE AU CAPITAL DE GB HOLDING PAR EXERCICE DE BSA POUR 0,5 M€ ET ENGAGEMENT DE CONSERVATION D’ACTIONSEU:ALNFLNFL Biosciences SA
      06/28/202311:45AMGlobeNewswire Inc.NFL BIOSCIENCES : COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 27 JUIN 2023EU:ALNFLNFL Biosciences SA
      06/28/202311:45AMGlobeNewswire Inc.NFL BIOSCIENCES : RESULTS OF THE COMBINED GENERAL MEETING OF JUNE 27, 2023EU:ALNFLNFL Biosciences SA
      06/21/202312:15PMGlobeNewswire Inc.NFL BIOSCIENCES: Approval for its patent to be granted on NFL-101 in Europe and approval of the clinical development plan for NFL-101 by the EMAEU:ALNFLNFL Biosciences SA
      06/21/202312:15PMGlobeNewswire Inc.NFL BIOSCIENCES : Accord de délivrance de son brevet sur NFL-101 en Europe et validation du plan de développement clinique de NFL-101 par l’EMAEU:ALNFLNFL Biosciences SA
      06/09/202311:45AMGlobeNewswire Inc.NFL Biosciences : Modalités de mise à disposition et consultation des documents préparatoires à l'Assemblée Générale Mixte du 27 juin 2023EU:ALNFLNFL Biosciences SA
      05/09/202311:45AMGlobeNewswire Inc.NFL Biosciences : Finalisation des recrutements de l’étude PRECESTOEU:ALNFLNFL Biosciences SA
      05/09/202311:45AMGlobeNewswire Inc.NFL Biosciences: Recruitment completed for the PRECESTO studyEU:ALNFLNFL Biosciences SA
      04/28/202311:45AMGlobeNewswire Inc.NFL Biosciences : Mise à disposition du Rapport Annuel au 31/12/2022EU:ALNFLNFL Biosciences SA
      04/28/202311:45AMGlobeNewswire Inc.NFL BIOSCIENCES : Rapport annuel au 31 décembre 2022EU:ALNFLNFL Biosciences SA
      04/25/20232:00AMGlobeNewswire Inc.NFL Biosciences: 2022 full-year business and earnings updateEU:ALNFLNFL Biosciences SA
      04/25/20232:00AMGlobeNewswire Inc.NFL Biosciences : Activités & Résultats annuels 2022EU:ALNFLNFL Biosciences SA
      02/27/202311:45AMGlobeNewswire Inc.Changes in the governance of NFL BiosciencesEU:ALNFLNFL Biosciences SA
      02/27/202311:45AMGlobeNewswire Inc.Évolution de la gouvernance de NFL BiosciencesEU:ALNFLNFL Biosciences SA
      02/22/202312:00PMGlobeNewswire Inc.NFL BIOSCIENCES : 1ère inclusion de volontaire dans l’étude PRECESTOEU:ALNFLNFL Biosciences SA
      02/22/202312:00PMGlobeNewswire Inc.NFL BIOSCIENCES: Inclusion of the first volunteer in the PRECESTO studyEU:ALNFLNFL Biosciences SA
      02/20/202311:45AMGlobeNewswire Inc.NFL Biosciences receives € 1.7 million in « Avance Innovation » funding from BpifranceEU:ALNFLNFL Biosciences SA
      02/20/202311:45AMGlobeNewswire Inc.NFL Biosciences obtient 1,7 million d’euros de financement « Avance Innovation » auprès de BpifranceEU:ALNFLNFL Biosciences SA
      02/20/202311:00AMGlobeNewswire Inc.NFL : bilan semestriel du contrat de liquidité 2ème semestre 2022EU:ALNFLNFL Biosciences SA
      02/02/202311:45AMGlobeNewswire Inc.NFL Biosciences collabore avec le CEAEU:ALNFLNFL Biosciences SA
      02/02/202311:45AMGlobeNewswire Inc.NFL Biosciences collaborates with the CEAEU:ALNFLNFL Biosciences SA
      01/31/20231:45AMGlobeNewswire Inc.NFL BIOSCIENCES : Très fort succès de l’augmentation de capital de NFL Biosciences avec plus de 3 millions d’euros levésEU:ALNFLNFL Biosciences SA
       Showing the most relevant articles for your search:EU:ALNFL